Selected research
Industry Growth & Trends
Global Zofenopril Industry Growth and Trends Forecast to 2032
Market perspective
The global Zofenopril market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Zofenopril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Zofenopril is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Zofenopril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Zofenopril include 2A PharmaChem, 3B Scientific, Advanced Synthesis Technologies, Alfa Chemistry, City Chemicals, Kanto Chemical, Nacalai Tesque, Pfaltz & Bauer and Wako Pure Chemical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Zofenopril market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Zofenopril market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zofenopril market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zofenopril.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Zofenopril market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Zofenopril Market by Company
2A PharmaChem
3B Scientific
Advanced Synthesis Technologies
Alfa Chemistry
City Chemicals
Kanto Chemical
Nacalai Tesque
Pfaltz & Bauer
Wako Pure Chemical Industries
Waterstone Technology
Lifecare Laboratories
LiangXiu Biotechnology
Zofenopril Segment by Type
Purity 98%
Purity 99%
Others
Zofenopril Segment by Application
Chemical Industry
Pharmaceutical Industry
Zofenopril Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zofenopril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zofenopril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zofenopril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zofenopril manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Zofenopril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98%
- Purity 99%
- Others
Applications
- Chemical Industry
- Pharmaceutical Industry
Companies covered
- 2A PharmaChem
- 3B Scientific
- Advanced Synthesis Technologies
- Alfa Chemistry
- City Chemicals
- Kanto Chemical
- Nacalai Tesque
- Pfaltz & Bauer
- Wako Pure Chemical Industries
- Waterstone Technology
- Lifecare Laboratories
- LiangXiu Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Zofenopril Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Zofenopril Sales Estimates and Forecasts (2021-2032)
- 1.3 Zofenopril Market by Type
- 1.3.1 Purity 98%
- 1.3.2 Purity 99%
- 1.3.3 Others
- 1.4 Global Zofenopril Market Size by Type
- 1.4.1 Global Zofenopril Market Size Overview by Type (2021-2032)
- 1.4.2 Global Zofenopril Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Zofenopril Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Zofenopril Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Zofenopril Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Zofenopril Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Zofenopril Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Zofenopril Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Zofenopril Industry Trends
- 2.2 Zofenopril Industry Drivers
- 2.3 Zofenopril Industry Opportunities and Challenges
- 2.4 Zofenopril Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Zofenopril Revenue (2021-2026)
- 3.2 Global Top Players by Zofenopril Sales (2021-2026)
- 3.3 Global Top Players by Zofenopril Price (2021-2026)
- 3.4 Global Zofenopril Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Zofenopril Major Company Production Sites & Headquarters
- 3.6 Global Zofenopril Company, Product Type & Application
- 3.7 Global Zofenopril Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Zofenopril Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Zofenopril Players Market Share by Revenue in 2025
- 3.8.3 2025 Zofenopril Tier 1, Tier 2, and Tier 3
4 Zofenopril Regional Status and Outlook
- 4.1 Global Zofenopril Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Zofenopril Historic Market Size by Region
- 4.2.1 Global Zofenopril Sales in Volume by Region (2021-2026)
- 4.2.2 Global Zofenopril Sales in Value by Region (2021-2026)
- 4.2.3 Global Zofenopril Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Zofenopril Forecasted Market Size by Region
- 4.3.1 Global Zofenopril Sales in Volume by Region (2027-2032)
- 4.3.2 Global Zofenopril Sales in Value by Region (2027-2032)
- 4.3.3 Global Zofenopril Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zofenopril by Application
- 5.1 Zofenopril Market by Application
- 5.1.1 Chemical Industry
- 5.1.2 Pharmaceutical Industry
- 5.2 Global Zofenopril Market Size by Application
- 5.2.1 Global Zofenopril Market Size Overview by Application (2021-2032)
- 5.2.2 Global Zofenopril Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Zofenopril Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Zofenopril Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Zofenopril Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Zofenopril Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Zofenopril Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Zofenopril Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 2A PharmaChem
- 6.1.1 2A PharmaChem Company Information
- 6.1.2 2A PharmaChem Business Overview
- 6.1.3 2A PharmaChem Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 2A PharmaChem Zofenopril Product Portfolio
- 6.1.5 2A PharmaChem Recent Developments
- 6.2 3B Scientific
- 6.2.1 3B Scientific Company Information
- 6.2.2 3B Scientific Business Overview
- 6.2.3 3B Scientific Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 3B Scientific Zofenopril Product Portfolio
- 6.2.5 3B Scientific Recent Developments
- 6.3 Advanced Synthesis Technologies
- 6.3.1 Advanced Synthesis Technologies Company Information
- 6.3.2 Advanced Synthesis Technologies Business Overview
- 6.3.3 Advanced Synthesis Technologies Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Advanced Synthesis Technologies Zofenopril Product Portfolio
- 6.3.5 Advanced Synthesis Technologies Recent Developments
- 6.4 Alfa Chemistry
- 6.4.1 Alfa Chemistry Company Information
- 6.4.2 Alfa Chemistry Business Overview
- 6.4.3 Alfa Chemistry Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Alfa Chemistry Zofenopril Product Portfolio
- 6.4.5 Alfa Chemistry Recent Developments
- 6.5 City Chemicals
- 6.5.1 City Chemicals Company Information
- 6.5.2 City Chemicals Business Overview
- 6.5.3 City Chemicals Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 City Chemicals Zofenopril Product Portfolio
- 6.5.5 City Chemicals Recent Developments
- 6.6 Kanto Chemical
- 6.6.1 Kanto Chemical Company Information
- 6.6.2 Kanto Chemical Business Overview
- 6.6.3 Kanto Chemical Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Kanto Chemical Zofenopril Product Portfolio
- 6.6.5 Kanto Chemical Recent Developments
- 6.7 Nacalai Tesque
- 6.7.1 Nacalai Tesque Company Information
- 6.7.2 Nacalai Tesque Business Overview
- 6.7.3 Nacalai Tesque Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nacalai Tesque Zofenopril Product Portfolio
- 6.7.5 Nacalai Tesque Recent Developments
- 6.8 Pfaltz & Bauer
- 6.8.1 Pfaltz & Bauer Company Information
- 6.8.2 Pfaltz & Bauer Business Overview
- 6.8.3 Pfaltz & Bauer Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pfaltz & Bauer Zofenopril Product Portfolio
- 6.8.5 Pfaltz & Bauer Recent Developments
- 6.9 Wako Pure Chemical Industries
- 6.9.1 Wako Pure Chemical Industries Company Information
- 6.9.2 Wako Pure Chemical Industries Business Overview
- 6.9.3 Wako Pure Chemical Industries Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Wako Pure Chemical Industries Zofenopril Product Portfolio
- 6.9.5 Wako Pure Chemical Industries Recent Developments
- 6.10 Waterstone Technology
- 6.10.1 Waterstone Technology Company Information
- 6.10.2 Waterstone Technology Business Overview
- 6.10.3 Waterstone Technology Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Waterstone Technology Zofenopril Product Portfolio
- 6.10.5 Waterstone Technology Recent Developments
- 6.11 Lifecare Laboratories
- 6.11.1 Lifecare Laboratories Company Information
- 6.11.2 Lifecare Laboratories Business Overview
- 6.11.3 Lifecare Laboratories Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Lifecare Laboratories Zofenopril Product Portfolio
- 6.11.5 Lifecare Laboratories Recent Developments
- 6.12 LiangXiu Biotechnology
- 6.12.1 LiangXiu Biotechnology Company Information
- 6.12.2 LiangXiu Biotechnology Business Overview
- 6.12.3 LiangXiu Biotechnology Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 LiangXiu Biotechnology Zofenopril Product Portfolio
- 6.12.5 LiangXiu Biotechnology Recent Developments
7 North America by Country
- 7.1 North America Zofenopril Sales by Country
- 7.1.1 North America Zofenopril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Zofenopril Sales by Country (2021-2026)
- 7.1.3 North America Zofenopril Sales Forecast by Country (2027-2032)
- 7.2 North America Zofenopril Market Size by Country
- 7.2.1 North America Zofenopril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Zofenopril Market Size by Country (2021-2026)
- 7.2.3 North America Zofenopril Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Zofenopril Sales by Country
- 8.1.1 Europe Zofenopril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Zofenopril Sales by Country (2021-2026)
- 8.1.3 Europe Zofenopril Sales Forecast by Country (2027-2032)
- 8.2 Europe Zofenopril Market Size by Country
- 8.2.1 Europe Zofenopril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Zofenopril Market Size by Country (2021-2026)
- 8.2.3 Europe Zofenopril Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Zofenopril Sales by Country
- 9.1.1 Asia-Pacific Zofenopril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Zofenopril Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Zofenopril Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Zofenopril Market Size by Country
- 9.2.1 Asia-Pacific Zofenopril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Zofenopril Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Zofenopril Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Zofenopril Sales by Country
- 10.1.1 South America Zofenopril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Zofenopril Sales by Country (2021-2026)
- 10.1.3 South America Zofenopril Sales Forecast by Country (2027-2032)
- 10.2 South America Zofenopril Market Size by Country
- 10.2.1 South America Zofenopril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Zofenopril Market Size by Country (2021-2026)
- 10.2.3 South America Zofenopril Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Zofenopril Sales by Country
- 11.1.1 Middle East and Africa Zofenopril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Zofenopril Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Zofenopril Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Zofenopril Market Size by Country
- 11.2.1 Middle East and Africa Zofenopril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Zofenopril Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Zofenopril Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Zofenopril Value Chain Analysis
- 12.1.1 Zofenopril Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Zofenopril Production Mode & Process
- 12.2 Zofenopril Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Zofenopril Distributors
- 12.2.3 Zofenopril Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst